DiaMedica Therapeutics Provides a Business Update and Announces Second Quarter 2023 Financial Results

Go back to DiaMedica Therapeutics Provides a Business Update and Announces Second Quarter 2023 Financial Results
(NASDAQ: DMAC) Delayed: 7.04 --0 (-0%)
Previous Close $7.04    52 Week High
Open $7.04    52 Week Low
Day High $7.04    P/E N/A 
Day Low $7.04    EPS
Volume 237